These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23398201)

  • 1. PNPLA3/adiponutrin functions in lipid droplet formation.
    Chamoun Z; Vacca F; Parton RG; Gruenberg J
    Biol Cell; 2013 May; 105(5):219-233. PubMed ID: 23398201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes.
    Yang A; Mottillo EP; Mladenovic-Lucas L; Zhou L; Granneman JG
    Nat Metab; 2019 May; 1(5):560-569. PubMed ID: 31497752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNPLA3 mediates hepatocyte triacylglycerol remodeling.
    Ruhanen H; Perttilä J; Hölttä-Vuori M; Zhou Y; Yki-Järvinen H; Ikonen E; Käkelä R; Olkkonen VM
    J Lipid Res; 2014 Apr; 55(4):739-46. PubMed ID: 24511104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.
    Huang Y; Cohen JC; Hobbs HH
    J Biol Chem; 2011 Oct; 286(43):37085-93. PubMed ID: 21878620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
    Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PNPLA3 in health and disease.
    Pingitore P; Romeo S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):900-906. PubMed ID: 29935383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.
    Smagris E; BasuRay S; Li J; Huang Y; Lai KM; Gromada J; Cohen JC; Hobbs HH
    Hepatology; 2015 Jan; 61(1):108-18. PubMed ID: 24917523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
    Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
    J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.
    Mitsche MA; Hobbs HH; Cohen JC
    J Biol Chem; 2018 May; 293(18):6958-6968. PubMed ID: 29555681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
    Luukkonen PK; Qadri S; Lehtimäki TE; Juuti A; Sammalkorpi H; Penttilä AK; Hakkarainen A; Orho-Melander M; Arola J; Yki-Järvinen H
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e300-e315. PubMed ID: 33064150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of diverse lipid droplet targeting motifs in the PNPLA family of triglyceride lipases.
    Murugesan S; Goldberg EB; Dou E; Brown WJ
    PLoS One; 2013; 8(5):e64950. PubMed ID: 23741432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans.
    Peter A; Kovarova M; Nadalin S; Cermak T; Königsrainer A; Machicao F; Stefan N; Häring HU; Schleicher E
    Diabetologia; 2014 Oct; 57(10):2103-7. PubMed ID: 24972532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
    Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
    J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.
    Hao L; Ito K; Huang KH; Sae-tan S; Lambert JD; Ross AC
    Metabolism; 2014 Oct; 63(10):1352-62. PubMed ID: 25060692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of lipid droplet proteins in liver diseases.
    Carr RM; Ahima RS
    Exp Cell Res; 2016 Jan; 340(2):187-92. PubMed ID: 26515554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression.
    Wieser V; Adolph TE; Enrich B; Moser P; Moschen AR; Tilg H
    Liver Int; 2017 Feb; 37(2):299-306. PubMed ID: 27514759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
    Hyysalo J; Gopalacharyulu P; Bian H; Hyötyläinen T; Leivonen M; Jaser N; Juuti A; Honka MJ; Nuutila P; Olkkonen VM; Oresic M; Yki-Järvinen H
    Diabetes; 2014 Jan; 63(1):312-22. PubMed ID: 24009255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.